Sammarco, E.; Manfredi, F.; Nuzzo, A.; Ferrari, M.; Bonato, A.; Salfi, A.; Serafin, D.; Zatteri, L.; Antonuzzo, A.; Galli, L.
Immune Checkpoint Inhibitor Rechallenge in Renal Cell Carcinoma: Current Evidence and Future Directions. Cancers 2023, 15, 3172.
https://doi.org/10.3390/cancers15123172
AMA Style
Sammarco E, Manfredi F, Nuzzo A, Ferrari M, Bonato A, Salfi A, Serafin D, Zatteri L, Antonuzzo A, Galli L.
Immune Checkpoint Inhibitor Rechallenge in Renal Cell Carcinoma: Current Evidence and Future Directions. Cancers. 2023; 15(12):3172.
https://doi.org/10.3390/cancers15123172
Chicago/Turabian Style
Sammarco, Enrico, Fiorella Manfredi, Amedeo Nuzzo, Marco Ferrari, Adele Bonato, Alessia Salfi, Debora Serafin, Luca Zatteri, Andrea Antonuzzo, and Luca Galli.
2023. "Immune Checkpoint Inhibitor Rechallenge in Renal Cell Carcinoma: Current Evidence and Future Directions" Cancers 15, no. 12: 3172.
https://doi.org/10.3390/cancers15123172
APA Style
Sammarco, E., Manfredi, F., Nuzzo, A., Ferrari, M., Bonato, A., Salfi, A., Serafin, D., Zatteri, L., Antonuzzo, A., & Galli, L.
(2023). Immune Checkpoint Inhibitor Rechallenge in Renal Cell Carcinoma: Current Evidence and Future Directions. Cancers, 15(12), 3172.
https://doi.org/10.3390/cancers15123172
